These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 20347331

  • 21. European Pharmacopoeia (EP), USDA and MAFF standards--will they ever be harmonised under the VICH umbrella?
    Castle P.
    Dev Biol (Basel); 2005; 121():227-34. PubMed ID: 15962485
    [Abstract] [Full Text] [Related]

  • 22. Viral safety in homoeopathic medicinal products.
    Schultz N, Franck-Karl G, Schilk J, Rose N.
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):55-65. PubMed ID: 21619856
    [Abstract] [Full Text] [Related]

  • 23. Presentation of the EEC directive (81/852)--quality.
    Lee AM.
    Dev Biol Stand; 1992 Jun; 79():39-41. PubMed ID: 1286763
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Risk management, cGMP, and the evolution of aseptic processing technology.
    Agalloco J, Akers J, Baseman H, Boeh R, Madsen R, Ostrove S, Pavell A.
    PDA J Pharm Sci Technol; 2009 Jun; 63(1):8-10. PubMed ID: 19455938
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 30. Development, standardization and assessment of PCR systems for purity testing of avian viral vaccines.
    Ottiger HP.
    Biologicals; 2010 May; 38(3):381-8. PubMed ID: 20338785
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Analytical method transfer: new descriptive approach for acceptance criteria definition.
    de Fontenay G.
    J Pharm Biomed Anal; 2008 Jan 07; 46(1):104-12. PubMed ID: 17961955
    [Abstract] [Full Text] [Related]

  • 35. Control of product batches (before and after registration). The German approach.
    Jungbäck C.
    Dev Biol Stand; 1992 Jan 07; 79():171-4. PubMed ID: 1286753
    [Abstract] [Full Text] [Related]

  • 36. Analysis of risk to biomedical products developed from animal sources (with special emphasis on the spongiform encephalopathy agents, scrapie and BSE).
    Rohwer RG.
    Dev Biol Stand; 1996 Jan 07; 88():247-56. PubMed ID: 9119146
    [Abstract] [Full Text] [Related]

  • 37. Considerations for setting the specifications of vaccines.
    Minor P.
    Expert Rev Vaccines; 2012 May 07; 11(5):579-85. PubMed ID: 22827243
    [Abstract] [Full Text] [Related]

  • 38. Regulatory constraints as seen from the pharmaceutical industry.
    Galligani G, David-Andersen I, Fossum B.
    Dev Biol (Basel); 2005 May 07; 121():235-41. PubMed ID: 15962486
    [Abstract] [Full Text] [Related]

  • 39. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun 07; 16(89):126-8. PubMed ID: 17585428
    [Abstract] [Full Text] [Related]

  • 40. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ, Wang T, Antonucci V, Dowling T, Ge Z, Ellison D, Curran J, Mohan G, Wyvratt J.
    J Pharm Biomed Anal; 2009 Dec 05; 50(5):794-6. PubMed ID: 19596534
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.